Zobrazeno 1 - 10
of 49
pro vyhledávání: '"J, Oglobine"'
Publikováno v:
British Journal of Cancer
Urokinase-type plasminogen activator (uPA) is a potentially important prognostic factor in breast cancer for identifying patients at high risk of recurrence. This retrospective study assessed two enzyme-linked immunosorbent assay (ELISA) methods meas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bb54c6f6946ee7ee97585ba6c3ba2541
https://doi.org/10.1038/bjc.1998.246
https://doi.org/10.1038/bjc.1998.246
Publikováno v:
British Journal of Cancer
It is now clearly established that proteolytic enzymes, including plasminogen activator (uPA), play an important role in breaking down the extracellular matrix, which is considered to be a step in metastasis formation. Plasminogen activators are cont
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e2084d999a25795f7be79e23026e1ebc
https://doi.org/10.1038/bjc.1994.74
https://doi.org/10.1038/bjc.1994.74
Autor:
C, Bouchet, K, Hacène, P M, Martin, V, Becette, M, Tubiana-Hulin, S, Lasry, J, Oglobine, F, Spyratos
Publikováno v:
Pathologie-biologie. 48(9)
Among the proteases involved in the tumor invasion process, components of the plasminogen activator system (plasminogen activator type-urokinase uPA, its membrane receptor uPAR and its two inhibitors PAI-1 and PAI-2) appear to define high risk patien
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f26f681b87110f606d26d38bbfbcd3a1
https://pubmed.ncbi.nlm.nih.gov/11141918
https://pubmed.ncbi.nlm.nih.gov/11141918
Autor:
S, Romain, F, Spyratos, C, Lainé-Bidron, C, Bouchet, O, Guirou, P M, Martin, J, Oglobine, H, Magdelénat
Publikováno v:
European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies. 33(9)
The urokinase type plasminogen activator (u-PA) and the plasminogen activator inhibitor-1 (PAI-1) are among the best second-generation prognostic tissue factors in breast cancer. However, different extraction procedures and assay kits are used in dif
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::199870434a3fa46a34b466e162d916b8
https://pubmed.ncbi.nlm.nih.gov/8611670
https://pubmed.ncbi.nlm.nih.gov/8611670
Publikováno v:
Bulletin du cancer. 81(9)
It is now clearly established that proteolytic enzymes, and in particular plasminogen activator (uPA), play an important role in breaking down the extracellular matrix, which is considered to be a step in metastasis formation. Plasminogen activators
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::8fcd4ff0955bec68010b5fdbefbcc7d5
https://pubmed.ncbi.nlm.nih.gov/7703566
https://pubmed.ncbi.nlm.nih.gov/7703566
Autor:
A. Desplaces, J. Oglobine, N. Pourreau-Schneider, Kamel Hacène, Pierre-Marie Martin, D. Foucre, A. Gentile, C Bouchet
Publikováno v:
British Journal of Cancer
The concentrations of cathepsin D (Cath D), urokinase (uPA) and two plasminogen activator inhibitors (PAI-1 and PAI-2) were analysed in the cytosols of 130 human mammary tumours (43 benign tumours and 87 primary and unilateral breast carcinomas). uPA
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d462aea0dc228c4f9f75c4e57ab99991
https://pubmed.ncbi.nlm.nih.gov/1931618
https://pubmed.ncbi.nlm.nih.gov/1931618
Autor:
J. Oglobine, F. Spyratos
Publikováno v:
European Journal of Cancer. 31:S72
Cancer invasion is dependent on a combined action of several proteolytic enzymes, such as collagenases, other metalloproteases, and serine proteases. Cathepsin-D was the first example of a protease whose immunoassay in the cytosol of breast tumors wa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ecac9a72a36fec61bd282faf08a51e5f
https://doi.org/10.1016/0959-8049(95)95594-v
https://doi.org/10.1016/0959-8049(95)95594-v
Publikováno v:
Annals of the New York Academy of Sciences. 464:531-533
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a59c6a774adb53c07ebb847360ae4f99
https://doi.org/10.1111/j.1749-6632.1986.tb16057.x
https://doi.org/10.1111/j.1749-6632.1986.tb16057.x
This data demonstrated that breast carcinoma lymphocytes were modified for IL2 regulation. The irradiation of lymphocytes inactivated the suppressor cells, but the result of this irradiation was not the same in benign and malignant patients. A decrea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6a1aaa404e7a209c268617f0f590206d
https://doi.org/10.1016/b978-0-08-031739-7.50206-8
https://doi.org/10.1016/b978-0-08-031739-7.50206-8
Publikováno v:
European journal of cancerclinical oncology. 22(1)
Primary breast cancers from 85 patients undergoing post-surgical adjuvant chemotherapy were analyzed for five glycolytic enzymes: lactate dehydrogenase (LDH); phosphohexose isomerase (PHI); glucose-6-phosphate dehydrogenase (G-6PD); pyruvate-kinase (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ad06afa2c7a37911984b9d89f70222c1
https://pubmed.ncbi.nlm.nih.gov/3956556
https://pubmed.ncbi.nlm.nih.gov/3956556